血清25(OH)D与冠心病患者复发性心血管事件风险的关联
基于英国生物银行22571例冠心病患者的前瞻性队列分析显示,血清25(OH)D中位浓度44.8 nmol/L,中位随访11.2年发生3998例复发性心血管事件。血清25(OH)D与复发性心血管事件呈非线性负相关,风险下降在约50 nmol/L处趋于平缓,且该关联不受维生素D受体基因变异修饰。
要点
- 血清25(OH)D与复发性心血管事件呈非线性负相关,P非线性<.01。
- 与25(OH)D<25.0 nmol/L者相比,50.0–74.9 nmol/L者复发性心血管事件HR为0.64(0.58–0.71)。
- 风险下降在约50 nmol/L处趋于平缓,该关联不受VDR基因变异修饰。
核心结论
- 在已确诊冠心病的人群中,较高的血清25(OH)D浓度与较低的复发性心血管事件风险呈非线性关联,潜在阈值约为50 nmol/L。
- 作者认为这些发现强调维持充足维生素D状态对冠心病患者预防复发性心血管事件的重要性。
研究设计与样本
- 研究为来自英国生物银行(UK Biobank)的队列分析,共纳入22571例冠心病患者。
- 复发性心血管事件包括心肌梗死、心力衰竭、卒中和心血管疾病死亡,通过电子健康记录识别。
- 采用Cox比例风险模型计算风险比(HR)及95%CI。
主要发现
- 血清25(OH)D浓度中位数(四分位间距)为44.8 nmol/L(范围30.3–61.4 nmol/L),58.6%的参与者25(OH)D低于50 nmol/L。
- 中位随访11.2年期间,共记录3998例复发性心血管事件。
- 多变量调整后,血清25(OH)D与复发性心血管事件呈非线性负相关(P非线性<.01),风险下降在约50 nmol/L处逐渐趋于平缓。
- 与血清25(OH)D低于25.0 nmol/L的参与者相比,血清25(OH)D为50.0–74.9 nmol/L者的复发性心血管事件HR为0.64(95%CI 0.58–0.71),心肌梗死HR为0.78(95%CI 0.65–0.94),心力衰竭HR为0.66(95%CI 0.57–0.76),卒中HR为0.66(95%CI 0.52–0.84)。
- 上述关联未受维生素D受体(VDR)基因变异修饰。
关键数值与推荐
- 血清25(OH)D与复发性心血管事件非线性关联的P非线性<.01。
- 与25(OH)D<25.0 nmol/L者相比,50.0–74.9 nmol/L者复发性心血管事件HR为0.64(95%CI 0.58–0.71)。
- 与25(OH)D<25.0 nmol/L者相比,50.0–74.9 nmol/L者心肌梗死HR为0.78(95%CI 0.65–0.94)。
- 与25(OH)D<25.0 nmol/L者相比,50.0–74.9 nmol/L者心力衰竭HR为0.66(95%CI 0.57–0.76)。
- 与25(OH)D<25.0 nmol/L者相比,50.0–74.9 nmol/L者卒中HR为0.66(95%CI 0.52–0.84)。
临床怎么用
- 原文结论指出,这些发现强调在冠心病患者中维持充足维生素D状态对预防复发性心血管事件的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Few studies have examined the relationship between vitamin D and the risk of recurrent cardiovascular (CV) events in people with coronary heart disease (CHD). OBJECTIVE: This study aimed to investigate the associations of serum 25-hydroxyvitamin D (25(OH)D) concentration and the vitamin D receptor (VDR) polymorphisms with the risk of recurrent CV events in individuals with established CHD. METHODS: A total of 22 571 participants with CHD were included from the UK Biobank. Recurrent CV events, including myocardial infarction (MI), heart failure (HF), stroke, and CV disease mortality, were identified from electronic health records. Cox proportional-hazard models were used to calculate hazard ratios (HRs) and 95% CIs. RESULTS: The median (interquartile range) of serum 25(OH)D concentration was 44.8 nmol/L (range, 30.3-61.4 nmol/L), and 58.6% of participants had 25(OH)D below 50 nmol/L. During a median follow-up of 11.2 years, a total of 3998 recurrent CV events were documented. After multivariable adjustment, there was a nonlinear inverse relationship between serum 25(OH)D and recurrent CV events (P nonlinearity <.01), and the decreasing risk gradually leveled off at around 50 nmol/L. Compared with participants with serum 25(OH)D less than 25.0 nmol/L, the HRs (95% CIs) for participants with serum 25(OH)D of 50.0 to 74.9 nmol/L were 0.64 (0.58-0.71) for recurrent CV events, 0.78 (0.65-0.94) for MI, 0.66 (0.57-0.76) for HF, and 0.66 (0.52-0.84) for stroke. In addition, these associations were not modified by genetic variants in the VDR. CONCLUSION: In people with established CHD, higher serum 25(OH)D concentrations were nonlinearly associated with a lower risk of recurrent CV events, with a potential threshold around 50 nmol/L. These findings highlight the importance of maintaining adequate vitamin D status in the prevention of recurrent CV events among individuals with CHD.
引用
- Lin X, Chen X, Liu S, et al. Associations of Serum 25(OH)D With Risk of Recurrent Cardiovascular Events in Individuals With Coronary Heart Disease. J Clin Endocrinol Metab. 2023. PMID: 37279959. doi:10.1210/clinem/dgad339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。